Search

everythinglearnresearchcommunity

for

Search:↓

A new genetic change causing early stop in the androgen receptor gene was found in a patient with androgen insensitivity syndrome.

IGFBP-rP1 could be a new treatment for a common type of hair loss.

Oral and topical tofacitinib can effectively treat severe hair loss with minimal side effects.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Trichothiodystrophy is a condition with brittle hair and various physical and mental issues due to low sulfur in proteins.

The new antibody, TYHF-1, specifically targets certain hair-related structures.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Aire mutation reduces alopecia areata, while Notch4 mutation prevents it in mice.

Minoxidil helps hair growth by promoting stem cell differentiation through increased ATP synthase activity.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

The research suggests that Tourette syndrome is linked to both brain signaling and immune system pathways.

Fatty acid transport protein 4 is essential for skin and hair development.

JAM-A modification speeds up skin wound healing by boosting fibroblast growth.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

AGC2-1 protein is essential for root hair growth in Arabidopsis.

Overexpressing AVP1 and AtNHX1 in plants improves salt tolerance and root hair development.

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

Upadacitinib effectively improved severe atopic dermatitis and alopecia universalis in a 29-year-old man.

Oral isotretinoin temporarily improved skin symptoms in a child with IFAP syndrome.

The peptide IMT-P8 can effectively deliver proteins into the skin and cells for potential skin treatments.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Nuclear Factor I-C is important for controlling hair growth by affecting the TGF-β1 pathway.

A patient with complete hair loss regrew all her hair using tofacitinib.

Polyamines, especially spermidine, are essential for hair growth.

TQC shows promise for better hair regrowth in treating hair loss.